FIELD: biotechnology.
SUBSTANCE: invention refers to biotechnology and molecular biology. Disclosed is a modified polypeptide for treating or preventing an influenza A infection, a sequence of which is at least 95 % identical to a sequence of reference haemagglutinin H5 (HA H5) or sequence of its corresponding portion, wherein said reference HA H5 is selected from a group consisting of HA virus of influenza A/Egypt/N03450/2009 ("Egy09") of wild type and HA of influenza virus A/duck/Egypt/10185S S/2010 ("Egy 10").
EFFECT: invention can be used for treating or preventing influenza in medicine.
22 cl, 11 dwg, 2 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HEMAGGLUTININ POLYPEPTIDES, AND REAGENTS AND METHODS RELATING THERETO | 2011 |
|
RU2663718C2 |
| METHODS OF PRODUCING VIRAL PARTICLES WITH SIMPLIFIED SURFACE PROTEINS' GLYCOSYLATION | 2011 |
|
RU2607452C2 |
| HYPERGLYCOSYLATED BINDING POLYPEPTIDES | 2014 |
|
RU2708314C2 |
| MODIFIED INFLUENZA VIRUS FOR MONITORING AND INCREASING VACCINE EFFICACY | 2006 |
|
RU2420535C2 |
| SITE-SPECIFIC ANTIBODY-DRUG CONJUGATION BY MEANS OF GLYCOENGINEERING | 2014 |
|
RU2711935C2 |
| METHOD TO APPLY MODIFIED FLU VIRUS | 2006 |
|
RU2480480C2 |
| MODIFIED INFLUENZA VIRUS VACCINES | 2013 |
|
RU2552213C2 |
| NEUTRALISING ANTI-INFLUENZA A VIRUS ANTIBODIES AND USING THEM | 2009 |
|
RU2553325C2 |
| METHOD OF PRODUCING PLANT PROTEIN | 2010 |
|
RU2567012C2 |
| ANTIBODY AGAINST MUC1 | 2019 |
|
RU2792347C2 |
